Folasade May, MD, PhD
In the midst of a global pandemic, most people aren’t thinking about routine screening for colorectal cancer. But experts fret that a decline in screenings now will mean more late-stage diagnoses and cancer deaths down the road, especially in the most vulnerable groups of patients.
Boosting low rates of CRC screening already is a major focus for federally qualified health centers (FQHCs) like Tiburcio Vasquez Health Center and Northeast Valley Health Corporation